Logo for VBI Vaccines Inc

VBI Vaccines Investor Relations Material

Latest events

Logo for VBI Vaccines Inc

Fireside Chat

VBI Vaccines
Logo for VBI Vaccines

Q1 2024

15 May, 2024
Logo for VBI Vaccines

Q4 2023

16 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from VBI Vaccines Inc

Access all reports
VBI Vaccines Inc., also known as Variation Biotechnologies Inc., is a biopharmaceutical company focused on the development and commercialization of vaccines for infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a commercialized hepatitis B vaccine, and has several vaccine candidates in various stages of development. These include treatments for hepatitis B, glioblastoma, cytomegalovirus, and Zika virus, along with multiple coronavirus vaccine candidates. VBI Vaccines has significant collaborations with entities like GlaxoSmithKline, the National Research Council of Canada, and the Coalition for Epidemic Preparedness Innovations. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.